Project Grant R01AI184565
Award Date
8/15/24
Completion Date
7/31/29
Dollars Obligated
$404K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Charlottesville, VA, USA
Similar Awards
This federal Project Grant award for $633,074 was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the Sloan-Kettering Institute for Cancer Research. The grant supports research to define the mechanisms by which the placenta protects itself from harmful B cell and antibody responses, while preserving the ability to mount effective immune responses to foreign antigens during pregnancy. Key...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), totaling $793,102, will support research to investigate the interplay of maternal antibody and newborn vaccine responses to influenza virus infection. The goal is to effectively vaccinate young infants when maternal antibody is at high levels, such that as maternal antibody wanes, a protective anti-influenza response is...
This federal Project Grant award of $219,456 from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports research to understand how sterile inflammation at the maternal-fetal interface impacts the developing fetal immune system in a non-human primate model. The research aims to test the hypotheses that 1) injecting the clotting agent Tisseel into the maternal-fetal interface leads to placental inflammation, and 2) this...
This Project Grant award of $3,305,720.00 was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The objective is to define the impact of maternal viral infections and inflammation on immune programming within the fetal brain and lymphoid organs in a non-human primate (NHP) model. The key products and services to be delivered under this 5-year grant include: Using an ex vivo microculture model to...
This $318,085 Project Grant was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant aims to better understand the role of antibodies, antigens, and cellular immunity in controlling viral infections through Fc-dependent mechanisms like antibody-dependent cellular cytotoxicity (ADCC), antibody-dependent cellular phagocytosis (ADCP), and complement-dependent cytolysis (CDC). The research...
This $456,390.00 Project Grant was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant is intended to fund research to understand how antigen duration and vaccine construct modulate the infant immune response to influenza vaccines. Specifically, the research seeks to elucidate the mechanisms by which a prolonged antigen delivery approach can significantly increase protective antibody...
This federal Project Grant award for $857,346 was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The funding supports research to define the balance of activating and inhibitory signals present in healthy and acutely infected human tissues, which is relevant for understanding how immune quiescence is achieved while also maintaining immune responsiveness. The primary awardee is the Fred...
This $621,698 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to understand how hepatitis B virus (HBV) infection in mothers affects the immune response and HBV persistence in their offspring. The goal is to identify maternal HBV factors that promote viral replication and suppression of anti-HBV immunity in the offspring, as well as the molecular mechanisms by...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $184,896 to The Children's Hospital of Philadelphia (CHOP) over the period of Jan 9, 2025 to Dec 31, 2029. The grant supports research and career development activities focused on evaluating the potential of mRNA-lipid nanoparticle (mRNA-LNP) platforms and lipid nanoparticle (LNP) adjuvants to overcome maternal...
This Project Grant award, totaling $859,597, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award aims to develop a vaccine that can elicit broadly neutralizing antibodies (bNAbs) against the HIV-1 fusion peptide epitope, a major vulnerable site on the viral envelope protein. The key product being developed is a recombinant fusion immunogen combining the HIV-1 fusion peptide with...